Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.
A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback